Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D001593:Benzyl Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D010042:Ouabain / Q000037:antagonists & inhibitors; D011412:Propanolamines / Q000138:chemical synthesis* / Q000494:pharmacology; D014628:Vagotomy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001593:Benzyl Compounds; D011412:Propanolamines; D010042:Ouabain